Overview
Updated 14 Jul 2026
Tomas Neilan, MD, is Associate Professor of Medicine, Harvard Medical School at Massachusetts General Hospital. The public record shows 409 publications with 21,718 citations (h-index 70), centered on Chemotherapy-induced cardiotoxicity and mitigation, Cardiac Imaging and Diagnostics, Cancer Immunotherapy and Biomarkers. It also documents an investigator role on 3 registered clinical trials, industry payments reported by 10 companies, 5 NIH-funded awards (2016–2026).
- Most recent indexed publication: 2026 · Journal of the American Heart Association
- Top research focus: Chemotherapy-induced cardiotoxicity and mitigation
- 3 registered trials on ClinicalTrials.gov
- Open Payments reporting from 10 companies
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Drugs & moleculesacross trials, industry payments and publications
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID; 19 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 183.
Clinical & industrytrials, payments and federal funding
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 3 registered studies on ClinicalTrials.gov. The most recent:
- STOP-CA (Statins TO Prevent the Cardiotoxicity From Anthracyclines)
Sponsor: Massachusetts General Hospital
InvestigatorPhase 2CompletedNCT02943590 - Cardiac Fibrosis by CMR in Patients With Cancer
Sponsor: Massachusetts General Hospital
InvestigatorWithdrawnNCT01906437
Industry payments
Updated 14 Jul 2026
10 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Merck Sharp & Dohme LLCProgram year20254 payments$40,640openpaymentsdata.cms.gov ↗
- GlaxoSmithKline, LLC.Program year20253 payments
- E.R. Squibb & Sons, L.L.C.Program year20253 payments
NIH funding
Updated 14 Jul 2026
5 NIH research awards on record, funded 2016–2026 per NIH RePORTER. The latest:
- Immune checkpoint inhibitors and accelerated coronary atherosclerosis
Massachusetts General Hospital
FY2026$1,145,094R01HL159187 - Immune checkpoint inhibitors and accelerated coronary atherosclerosis
Massachusetts General Hospital
FY2025$1,023,526R01HL159187 - Cardiovascular Diseases among Patients with Cancer and Patients living with HIV
Massachusetts General Hospital
FY2025$133,685K24HL150238
Congress activity
Updated 14 Jul 2026
21 congress contributions (2018–2026) across AACR, ASCO, ASH, ASTRO, ESMO per OpenAlex. The most recent:
- Abstract 4790: Cancer reprograms the remote vascular microenvironment to promote atherosclerosis
AACR Annual Meeting
AACR2026Co-author - Abstract 7474: T-cell responses across heart, blood, and tumor in patients with immune checkpoint inhibitor-related myocarditis (irMyocarditis)
AACR Annual Meeting
AACR2024Co-author - Detection of immune-related adverse events among hospitalized patients using large language models.
ASCO Annual Meeting
ASCO2024Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 14 Jul 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Immune Checkpoint Inhibitors, Atherosclerotic Cardiovascular Events, and Plaque Progression Among Women With Cancer.
Journal of the American Heart Association
2026 - Predictors of Long-Term Survival in Patients With Immune Checkpoint Inhibitor-Associated Myocarditis.
Journal of the American Heart Association
2025 - Associations Between Social Determinants of Health, Allostatic Load, and Anthracycline Cardiotoxicity in a Diverse Patient Population.
Journal of the American Heart Association
2025
Most-cited worksby citation count (OpenAlex)
- 02Myocarditis in Patients Treated With Immune Checkpoint Inhibitors1,551 citations2018
- 03Efficacy of Tocilizumab in Patients Hospitalized with Covid-191,435 citations2020
- 05
Contact
An office address from a public listing. This research profile has no federal registry record to draw from.
Office address
165 Cambridge Street, Suite 400, Boston, MA 02114
Network
Updated 14 Jul 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- MD (MBBCH, BAO)
University College Dublin Medical School
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cvrc.massgeneral.org ↗ - MPH
Harvard T.H. Chan School of Public Health
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cvrc.massgeneral.org ↗ - Board Certified
Internal Medicine, American Board of Internal Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →massgeneral.org ↗
Editorial & leadership rolesjournal and society appointments
Awards & honorshonors on the public record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →irishamerica.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cvrc.massgeneral.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cvrc.massgeneral.org ↗
Secondary affiliationsappointments beyond the home institution
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.massgeneralbrigham.org ↗
- Associate Director
MGH T32 Training Program in Cardiovascular Imaging
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →acc.org ↗
Media & interviewspress, podcasts and appearances
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ic-os.org ↗
- CardioNerds Podcast
Episode 365: "CardioOncology: Cardiotoxicity of Novel Immunotherapies with Dr. Tomas Neilan"
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cardionerds.com ↗ - Contributor
Mass General Advances in Motion (patient/physician education video and article series)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →advances.massgeneral.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Mentions by otherswhere others cite or feature them
- Other
aimssummit.com/team/tom-neilan
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aimssummit.com ↗ - Other
ic-os.org/find-a-cardiooncologist/tomas-neilan-md-mph
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ic-os.org ↗ - YouTube
youtube.com/watch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Jonathan Rosand, MD
Massachusetts General Hospital
- 910
- publications
- 117
- h-index
- 1
- trial
Timothy Wilens, MD
Massachusetts General Hospital
- 658
- publications
- 101
- h-index
- 8
- trials
Michael Schwarzschild, MD
Massachusetts General Hospital
- 348
- publications
- 86
- h-index
- 3
- trials
Richard Penson, MD
Massachusetts General Hospital
- 394
- publications
- 68
- h-index
- 9
- trials